-
Mashup Score: 2
Sophie Cousin, MD, Institut Bergonié, Bordeaux, France, talks on a post hoc analysis evaluating the efficacy and safety of lurbinectedin…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Interim results from ARCADIA trial: cabozantinib plus durvalumab in advanced urothelial carcinoma - 10 month(s) ago
Patrizia Giannatempo, MD, Foundation IRCCS National Cancer Institute, Milan, Italy, discusses the Phase II ARCADIA (NCT03824691) trial investigating the combination…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥@giannatempopatr discusses the promising interim results of the Phase II ARCADIA trial combining cabozantinib and durvalumab in advanced urothelial carcinoma. The therapy showed an ORR of 39.7% and manageable safety: ➡️https://t.co/XwN4YnPyfl⬅️ #UroOnc #ASCO23 #ImmunoOnc
-
-
Mashup Score: 1VJOncology – The video journal of oncology - 10 month(s) ago
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📢Don’t forget to check out https://t.co/ys1d8pDAKO for exclusive insight on the latest in GI oncology from #WCGIC23! @myESMO https://t.co/SewJ6AfQrF
-
-
Mashup Score: 0Updates in immunotherapy for head and neck cancer - 10 month(s) ago
In this podcast we’ll be covering some of the latest updates in immunotherapy for head and neck cancer. Ezra Cohen,…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎧In this podcast, we hear from @EzraACohen, @DrNabilSaba, @AriRosenbergMD, @BlessieNelson & @HSkinnerMDPhD as they share insights and updates in immunotherapy for head & neck cancer from #ASCO23: Listen here ➡️https://t.co/K7VjodkEHY⬅️ @ASCO #hncSM #ImmunoOnc
-
-
Mashup Score: 0Vaccine approaches to immune modulation - 10 month(s) ago
Lana Kandalaft, PhD, PharmD, MTR, University of Lausanne, Lausanne, Switzerland, highlighting the immunomodulatory role of vaccines in cancer treatment, emphasizing…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥Lana Kandalaft, PhD, PharmD, MTR, discusses the immunomodulatory role of cancer vaccines and their potential to improve outcomes. Vaccines can prime T-cells and enhance efficacy when combined with other treatments: ➡️https://t.co/MTFSfT99lC⬅️ #ASCO23 #ImmunoOnc
-
-
Mashup Score: 0Sub-analysis of STAMP trial: ctDNA as predictive biomarker for CCA monitoring during ACT - 10 month(s) ago
Changhoon Yoo, MD, PhD, Netherlands Cancer Institute, Amsterdam, Netherlands, provides an overview of a sub-analysis of the randomized Phase II…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥@changhoon_yoo of @NKI_nl discusses ctDNA as a predictive biomarker in cholangiocarcinoma. Study shows ctDNA-positive patients at baseline have shorter recurrence-free survival: ➡️https://t.co/E46QD4goA0⬅️ #ASCO23 #Oncology
-
-
Mashup Score: 2Sub-analysis of STAMP trial: ctDNA as predictive biomarker for CCA monitoring during ACT - 10 month(s) ago
Changhoon Yoo, MD, PhD, Netherlands Cancer Institute, Amsterdam, Netherlands, provides an overview of a sub-analysis of the randomized Phase II…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥@changhoon_yoo of @AsanMedicalCtr discusses ctDNA as a predictive biomarker in cholangiocarcinoma. Study shows ctDNA-positive patients at baseline have shorter recurrence-free survival: ➡️https://t.co/E46QD4goA0⬅️ #ASCO23 #Oncology
-
-
Mashup Score: 0VJOncology – The video journal of oncology - 10 month(s) ago
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Missed out on #ANZUP23? Catch up by heading to https://t.co/ys1d8pDAKO for on-demand interviews with leading experts in #genitourinary cancer! 🖥️ @VJOncology @ANZUPtrials #pcsm #blcsm #kcsm #tscsm #uroonc https://t.co/HK1b68TuX1
-
-
Mashup Score: 0HRQoL and pain outcomes in mCRPC: abi + ala vs abi + pbo in PROpel - 10 month(s) ago
Andrew J. Armstrong, MD, MSc, Duke Cancer Institute, Durham, NC, shares the health-related quality of life (HRQoL) and pain outcomes…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥@AarmstrongDuke of @DukeCancer shares exciting findings from PROpel trial in mCRPC: Abiraterone + Olaparib shows improved rPFS without impacting HRQoL: ➡️https://t.co/7p9FFyoogR #PCSM #UroOnc #ASCO2023 @ASCO
-
-
Mashup Score: 0VJOncology – The video journal of oncology - 10 month(s) ago
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
⭐It’s hard to pick a favorite moment from #WCGIC23, but don’t worry, you don’t have to. Instead, you can relive it all again at https://t.co/qH0bG8agF6! @myESMO https://t.co/Te5gOjS1N4
-
🎥Sophie Cousin, MD, of @BERGONIE33 discusses promising results of lurbinectedin for relapsed #SCLC in elderly patients, demonstrating higher response rates, longer survival, and a favorable safety profile compared to SOC: ➡️https://t.co/KkNOGr6C85⬅️ #ASCO23 #LungCancer #LCSM